Saad Amin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saad Amin has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Sajjad Ahmad
School of Sciences, Department of Biotechnology, Institute of Space Technology, Islamabad, Pakistan
3 shared publications - Asad Ullah
Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan
2 shared publications - Kalsoom Khan
Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan
2 shared publications Alhanouf I. Al-Harbi
Department of Medical Laboratory, College of Applied Medical Sciences in Yanbu Governorate, Taibah University, Yanbu 46411, Saudi Arabia
1 shared publication- Bader Alfardan
Department of Industrial Engineering, College of Engineering, King Khalid University, Abha, Saudi Arabia
1 shared publication - Dawood Ahmad
Institute of Biotechnology and Genetic Engineering (IBGE), The University of Agriculture, Peshawar, Pakistan
1 shared publication
Latest Publications
- 19 August 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 89
A GPT-Driven De Novo Discovery of SIRT2 Inhibitors Against Breast Cancer
- 19 August 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 89
A GPT-Driven De Novo Discovery of SIRT2 Inhibitors Against Breast Cancer
- 13 March 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (3) , 300
Identification of Novel Inhibitory Compounds against NDM-1, From High-Throughput Docking To Stability Analysis via Molecular Dynamics
- 13 March 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (3) , 300
Identification of Novel Inhibitory Compounds against NDM-1, From High-Throughput Docking To Stability Analysis via Molecular Dynamics
- 31 December 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2821-2833
Sequence Variation and Structural Insights into Porin Genes (OmpF, OmpC) of Wastewater-Derived Escherichia coli : A Molecular and Bioinformatics Approach
Multi-drug-resistant Escherichia coli is one of the most common waterborne pathogens, causing severe illnesses with limited treatment options. Hospital wastewater effluents containing unused and excreted drugs, including antibiotics, are considered the primary contributors to multidrug resistance in microorganisms. This wastewater is directly released into the environment, contaminating water sources. The study aimed to assess the occurrence, molecular and in silico characterization of antibiotic-resistant genes in E. coli isolated from three tertiary care units in Peshawar. Among the total 462 collected samples, 111 samples were positive for E. coli. These strains exhibited resistance to Ampicillin, Gentamycin, Tetracycline, Cefazolin, Ciprofloxacin, Penicillin, Cefepime, Ceftriaxone, Imipenem, Meronem, Amikacin, Norfloxacin, Fosfomycin, Levofloxacin, Tobramycin, Chloramphenicol, Colistin and Tigecycline, while varying susceptibility was shown to tigecycline, Fosfomycin, chloramphenicol and colistin. Among the resistant isolates (n [ ] 33), 18% of the isolates expressed OmpC, while OmpF was detected in 36% of the isolates. Following PCR, the products were subjected to next-generation sequencing due to its high accuracy in detecting mutations. Genetic analysis revealed G13E and G116E mutations in OmpF, while A239V and R292 L mutations were detected in OmpC. The conformational stability of wild and mutated proteins was estimated using a 100 ns molecular dynamics simulation. In brief, this study focused on discovering promising chemical entities that could support the development of in silico drug candidates targeting antibiotic-resistant strains of E. coli.
- 31 December 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2821-2833
Sequence Variation and Structural Insights into Porin Genes (OmpF, OmpC) of Wastewater-Derived Escherichia coli : A Molecular and Bioinformatics Approach
Multi-drug-resistant Escherichia coli is one of the most common waterborne pathogens, causing severe illnesses with limited treatment options. Hospital wastewater effluents containing unused and excreted drugs, including antibiotics, are considered the primary contributors to multidrug resistance in microorganisms. This wastewater is directly released into the environment, contaminating water sources. The study aimed to assess the occurrence, molecular and in silico characterization of antibiotic-resistant genes in E. coli isolated from three tertiary care units in Peshawar. Among the total 462 collected samples, 111 samples were positive for E. coli. These strains exhibited resistance to Ampicillin, Gentamycin, Tetracycline, Cefazolin, Ciprofloxacin, Penicillin, Cefepime, Ceftriaxone, Imipenem, Meronem, Amikacin, Norfloxacin, Fosfomycin, Levofloxacin, Tobramycin, Chloramphenicol, Colistin and Tigecycline, while varying susceptibility was shown to tigecycline, Fosfomycin, chloramphenicol and colistin. Among the resistant isolates (n [ ] 33), 18% of the isolates expressed OmpC, while OmpF was detected in 36% of the isolates. Following PCR, the products were subjected to next-generation sequencing due to its high accuracy in detecting mutations. Genetic analysis revealed G13E and G116E mutations in OmpF, while A239V and R292 L mutations were detected in OmpC. The conformational stability of wild and mutated proteins was estimated using a 100 ns molecular dynamics simulation. In brief, this study focused on discovering promising chemical entities that could support the development of in silico drug candidates targeting antibiotic-resistant strains of E. coli.
- 12 November 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2509-2532
Targeting Glycine N-Methyltransferase: A Computational Pipeline for Novel Anti-Pancreatic Cancer Leads
Glycine N-Methyltransferase (GNMT) has emerged as a potential drug target due to its pivotal role in pancreatic cancer development. This study utilized an integrated computational pipeline to identify promising novel GNMT inhibitors. The study was initiated by selecting overexpressed genes from microarray datasets, from which the five most overexpressed genes across the datasets were identified for further analysis: Albumin, Aquaporin 8, TMED6, Tex11 and GNMT. Three structurally diverse compound libraries, the FDA-approved ASINEX anticancer library, the comprehensive marine natural products database (CMNPD) and the Cambridge library, underwent extensive structure-based virtual screening via a molecular docking protocol, resulting in the selection of the top nine lead compounds, three from each library. The compounds are ASINEX — AAM_10789997, AEM_12453662 and ASN-12712084, while CMNPD — CMNPD4126, CMNPD4356 and CMNPD4327 and Cambridge — RAPAMYCIN, EVEROLIMUS and AZD2281. Their binding affinities were below −8 kcal/mol, suggesting stronger interaction and stability of GNMT-ligand complexes. Density Functional Theory (DFT) results have shown the stability and reactivity of these compounds. The selected lead compounds demonstrated a favorable pharmacokinetic profile, fulfilling the Lipinski Rule 5 criteria. Furthermore, the study was proceeded with molecular dynamics (MD) simulation of 100 ns to identify the interaction of GMNT-ligands under a dynamic environment. The RMSD of all compounds ranged from 2.61 to 3.95 Å. The post-simulation analysis, conducted with the aim of gaining a deeper insight into protein–ligand complexes, included principal component analysis (PCA), hydrogen bonding studies, secondary structure studies and salt bridge analysis. Furthermore, MMPB/GBSA calculations and entropy energy estimations were carried out for the validation of the energetic favorability of the selected leads. The study identified nine lead compounds with stronger interaction, structural stability and a promising pharmacokinetics profile, highlighting their potential as lead compounds for further development. Nevertheless, additional wet lab investigations are necessary to evaluate these drugs’ potential to combat cancer.
- 12 November 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2509-2532
Targeting Glycine N-Methyltransferase: A Computational Pipeline for Novel Anti-Pancreatic Cancer Leads
Glycine N-Methyltransferase (GNMT) has emerged as a potential drug target due to its pivotal role in pancreatic cancer development. This study utilized an integrated computational pipeline to identify promising novel GNMT inhibitors. The study was initiated by selecting overexpressed genes from microarray datasets, from which the five most overexpressed genes across the datasets were identified for further analysis: Albumin, Aquaporin 8, TMED6, Tex11 and GNMT. Three structurally diverse compound libraries, the FDA-approved ASINEX anticancer library, the comprehensive marine natural products database (CMNPD) and the Cambridge library, underwent extensive structure-based virtual screening via a molecular docking protocol, resulting in the selection of the top nine lead compounds, three from each library. The compounds are ASINEX — AAM_10789997, AEM_12453662 and ASN-12712084, while CMNPD — CMNPD4126, CMNPD4356 and CMNPD4327 and Cambridge — RAPAMYCIN, EVEROLIMUS and AZD2281. Their binding affinities were below −8 kcal/mol, suggesting stronger interaction and stability of GNMT-ligand complexes. Density Functional Theory (DFT) results have shown the stability and reactivity of these compounds. The selected lead compounds demonstrated a favorable pharmacokinetic profile, fulfilling the Lipinski Rule 5 criteria. Furthermore, the study was proceeded with molecular dynamics (MD) simulation of 100 ns to identify the interaction of GMNT-ligands under a dynamic environment. The RMSD of all compounds ranged from 2.61 to 3.95 Å. The post-simulation analysis, conducted with the aim of gaining a deeper insight into protein–ligand complexes, included principal component analysis (PCA), hydrogen bonding studies, secondary structure studies and salt bridge analysis. Furthermore, MMPB/GBSA calculations and entropy energy estimations were carried out for the validation of the energetic favorability of the selected leads. The study identified nine lead compounds with stronger interaction, structural stability and a promising pharmacokinetics profile, highlighting their potential as lead compounds for further development. Nevertheless, additional wet lab investigations are necessary to evaluate these drugs’ potential to combat cancer.